Current insights into the regulation of programmed cell death by NF-κB
暂无分享,去创建一个
C Gélinas | C. Gélinas | Yongjun Fan | Y. Fan | J. Dutta | N. Gupta | G. Fan | Y Fan | J Dutta | N Gupta | G Fan
[1] A. Strasser,et al. The role of Rel/NF-κB transcription factors in B lymphocyte survival , 2003 .
[2] G. Salvesen,et al. Neutralization of Smac/Diablo by Inhibitors of Apoptosis (IAPs) , 2004, Journal of Biological Chemistry.
[3] R. Schmid,et al. Constitutive NF-κB/Rel Activation in Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) , 2004 .
[4] Jennifer Y. Zhang,et al. NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia , 2003, Nature.
[5] Francesca Zazzeroni,et al. Linking JNK signaling to NF-κB: a key to survival , 2004, Journal of Cell Science.
[6] S. Catz,et al. Transcriptional regulation of bcl-2 by nuclear factor κB and its significance in prostate cancer , 2001, Oncogene.
[7] D. Green,et al. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1. , 1998, Molecular cell.
[8] L. Stark,et al. Nucleolar Sequestration of RelA (p65) Regulates NF-κB-Driven Transcription and Apoptosis , 2005, Molecular and Cellular Biology.
[9] T. Mak,et al. Deficiency of T2K leads to apoptotic liver degeneration and impaired NF‐κB‐dependent gene transcription , 2000, The EMBO journal.
[10] N. Perkins,et al. Regulation of NF‐κB and p53 through activation of ATR and Chk1 by the ARF tumour suppressor , 2005, The EMBO journal.
[11] T. Gilmore,et al. Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel , 2001, Oncogene.
[12] B. Dörken,et al. Constitutive NF-kappaB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells. , 2001, Blood.
[13] David Baltimore,et al. NF-κB functions in synaptic signaling and behavior , 2003, Nature Neuroscience.
[14] Shao-Cong Sun,et al. Negative Regulation of JNK Signaling by the Tumor Suppressor CYLD* , 2004, Journal of Biological Chemistry.
[15] L. Old,et al. Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[16] René Bernards,et al. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB , 2003, Nature.
[17] Robert Gilmore. Prolog: Marleys Geist , 1996 .
[18] Lin-Feng Chen,et al. NF-κB Is Essential for Induction of CYLD, the Negative Regulator of NF-κB , 2004, Journal of Biological Chemistry.
[19] P. Baeuerle,et al. Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B , 1990, Molecular and cellular biology.
[20] Michael Karin,et al. NF-κB at the crossroads of life and death , 2002, Nature Immunology.
[21] C. Albanese,et al. E2F1 and c-Myc potentiate apoptosis through inhibition of NF-kappaB activity that facilitates MnSOD-mediated ROS elimination. , 2002, Molecular cell.
[22] G. Haegeman,et al. Recruitment of IκBα to the hes1 promoter is associated with transcriptional repression , 2004 .
[23] Jennifer Y. Zhang,et al. CDK4 regulation by TNFR1 and JNK is required for NF-κB–mediated epidermal growth control , 2005, The Journal of cell biology.
[24] J. Tschopp,et al. Induction of TNF Receptor I-Mediated Apoptosis via Two Sequential Signaling Complexes , 2003, Cell.
[25] I. Verma,et al. IKK1-deficient mice exhibit abnormal development of skin and skeleton. , 1999, Genes & development.
[26] T. Golub,et al. NFkappaB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes. , 2005, Blood.
[27] D. Green,et al. Regulation of Fas-Ligand Expression during Activation-induced Cell Death in T Lymphocytes via Nuclear Factor κB* , 1999, The Journal of Biological Chemistry.
[28] B. Rayet,et al. Aberrant rel/nfkb genes and activity in human cancer , 1999, Oncogene.
[29] L. Salmena,et al. Requirement for Caspase-8 in NF-κB Activation by Antigen Receptor , 2005, Science.
[30] T. Behrens,et al. c-Rel Is Required for the Protection of B Cells from Antigen Receptor-Mediated, But Not Fas-Mediated, Apoptosis1 , 2001, The Journal of Immunology.
[31] S. Miyamoto,et al. Sequential Modification of NEMO/IKKγ by SUMO-1 and Ubiquitin Mediates NF-κB Activation by Genotoxic Stress , 2003, Cell.
[32] M. Karin,et al. IκB-kinaseβ-dependent NF-κB activation provides radioprotection to the intestinal epithelium , 2004 .
[33] A. Levine,et al. Activation of NF-κB and inhibition of p53-mediated apoptosis by API2/mucosa-associated lymphoid tissue 1 fusions promote oncogenesis , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[34] C. Gélinas,et al. Molecular Basis of Oncogenesis by NF-κB , 2006 .
[35] E. Zucca,et al. Delving deeper into MALT lymphoma biology. , 2005, The Journal of clinical investigation.
[36] P. Neiman,et al. Role of Nr13 in regulation of programmed cell death in the bursa of Fabricius. , 1999, Genes & development.
[37] M. Merville,et al. NF-κB-dependent MnSOD expression protects adenocarcinoma cells from TNF-α-induced apoptosis , 2002, Oncogene.
[38] Jonathan D. Licht,et al. BRCA1 Augments Transcription by the NF-κB Transcription Factor by Binding to the Rel Domain of the p65/RelA Subunit* , 2003, Journal of Biological Chemistry.
[39] David Baltimore,et al. An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death , 1996, Science.
[40] J C Reed,et al. A Single BIR Domain of XIAP Sufficient for Inhibiting Caspases* , 1998, The Journal of Biological Chemistry.
[41] C. Duckett. IAP proteins: sticking it to Smac. , 2005, The Biochemical journal.
[42] N. Perkins,et al. Differential regulation of NF-κB activation and function by topoisomerase II inhibitors , 2006, BMC Cancer.
[43] J. Woodgett,et al. Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation , 2000, Nature.
[44] N. Perkins,et al. Active Repression of Antiapoptotic Gene Expression by RelA(p65) NF-κB , 2004 .
[45] M. Peter,et al. Gadd45 beta mediates the protective effects of CD40 costimulation against Fas-induced apoptosis. , 2003, Blood.
[46] Peter Scheurich,et al. The Human Tumor Necrosis Factor (TNF) Receptor-associated Factor 1 Gene (TRAF1) Is Up-regulated by Cytokines of the TNF Ligand Family and Modulates TNF-induced Activation of NF-κB and c-Jun N-terminal Kinase* , 1999, The Journal of Biological Chemistry.
[47] C. Gandhi,et al. Inhibition of T‐cell responses by hepatic stellate cells via B7‐H1–mediated T‐cell apoptosis in mice , 2004, Hepatology.
[48] D. Bernard,et al. The c-Rel transcription factor can both induce and inhibit apoptosis in the same cells via the upregulation of MnSOD , 2002, Oncogene.
[49] J. Richardson,et al. Constitutive NF-kappaB activation, normal Fas-induced apoptosis, and increased incidence of lymphoma in human herpes virus 8 K13 transgenic mice. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[50] K. Okumura,et al. Reactive oxygen species mediate crosstalk between NF-κB and JNK , 2006, Cell Death and Differentiation.
[51] E. Kieff,et al. IL-1 receptor-associated kinase 1 is critical for latent membrane protein 1-induced p65/RelA serine 536 phosphorylation and NF-κB activation , 2006 .
[52] Brian J. Smith,et al. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. , 2005, Molecular cell.
[53] E. Kieff,et al. Epstein–Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKKα-dependent noncanonical NF-κB activation , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[54] L. Staudt,et al. The human B-cell lymphoma cell line RC-K8 has multiple genetic alterations that dysregulate the Rel/NF-κB signal transduction pathway , 2002, Oncogene.
[55] P. Scheurich,et al. Tumor Necrosis Factor (TNF) and Phorbol Ester Induce TNF-related Apoptosis-inducing Ligand (TRAIL) under Critical Involvement of NF-κB Essential Modulator (NEMO)/IKKγ* , 2001, The Journal of Biological Chemistry.
[56] Q Cheng,et al. NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[57] R. Korneluk,et al. The inhibitors of apoptosis: there is more to life than Bcl2 , 2003, Oncogene.
[58] S. Ghosh,et al. Inhibition of NF-kappa B by sodium salicylate and aspirin. , 1994, Science.
[59] Liming Wu,et al. The C-terminal Activating Region 2 of the Epstein-Barr Virus-encoded Latent Membrane Protein 1 Activates NF-κB through TRAF6 and TAK1* , 2006, Journal of Biological Chemistry.
[60] Francesca Zazzeroni,et al. Gadd45β mediates the NF-κB suppression of JNK signalling by targeting MKK7/JNKK2 , 2004, Nature Cell Biology.
[61] M. Karin,et al. The E3 Ubiquitin Ligase Itch Couples JNK Activation to TNFα-induced Cell Death by Inducing c-FLIPL Turnover , 2006, Cell.
[62] Kevin J. Tracey,et al. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal , 2005, Nature Reviews Immunology.
[63] A. E. Rogers,et al. Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer. , 1997, The Journal of clinical investigation.
[64] W. Funkhouser,et al. Selective activation of NF-κB subunits in human breast cancer: potential roles for NF-κB2/p52 and for Bcl-3 , 2000, Oncogene.
[65] C. Wijmenga,et al. A novel role for XIAP in copper homeostasis through regulation of MURR1 , 2004, The EMBO journal.
[66] C. Scheidereit,et al. Transcription factor NF-κB is constitutively activated in acute lymphoblastic leukemia cells , 2000, Leukemia.
[67] J. Sweatt,et al. A Bioinformatics Analysis of Memory Consolidation Reveals Involvement of the Transcription Factor c-Rel , 2004, The Journal of Neuroscience.
[68] T. Gilmore. Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel , 1999, Oncogene.
[69] John C. Wilkinson,et al. COMMD Proteins, a Novel Family of Structural and Functional Homologs of MURR1* , 2005, Journal of Biological Chemistry.
[70] A. Israël,et al. Forebrain-Specific Neuronal Inhibition of Nuclear Factor-κB Activity Leads to Loss of Neuroprotection , 2003, The Journal of Neuroscience.
[71] H. Kamata,et al. The Anti-Death Machinery in IKK/NF-κB Signaling , 2005, Journal of Clinical Immunology.
[72] E. Kieff,et al. Epstein–Barr virus latent membrane protein 1 activation of NF-κB through IRAK1 and TRAF6 , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[73] E. Nabel,et al. Protein Methyltransferase 2 Inhibits NF-κB Function and Promotes Apoptosis , 2006, Molecular and Cellular Biology.
[74] R. Beyaert,et al. A20 and A20-binding proteins as cellular inhibitors of nuclear factor-kappa B-dependent gene expression and apoptosis. , 2000, Biochemical pharmacology.
[75] Shai Shaham,et al. Death without caspases, caspases without death. , 2004, Trends in cell biology.
[76] D. Goeddel,et al. Embryonic Lethality, Liver Degeneration, and Impaired NF-κB Activation in IKK-β-Deficient Mice , 1999 .
[77] H. Kwon,et al. Hostile takeovers: viral appropriation of the NF-kB pathway , 2001 .
[78] R. Cardiff,et al. Oncogenic Signaling Pathways Activated in DMBA-Induced Mouse Mammary Tumors , 2005, Toxicologic pathology.
[79] D. Kalaitzidis,et al. Rel/NF-κB/IκB signal transduction in the generation and treatment of human cancer , 2002 .
[80] M. Lenardo,et al. Competitive Control of Independent Programs of Tumor Necrosis Factor Receptor-Induced Cell Death by TRADD and RIP1 , 2006, Molecular and Cellular Biology.
[81] C. Duckett,et al. Reawakening the cellular death program in neoplasia through the therapeutic blockade of IAP function. , 2005, The Journal of clinical investigation.
[82] P. Chaudhary,et al. Activation of alternative NF-κB pathway by human herpes virus 8-encoded Fas-associated death domain-like IL-1β-converting enzyme inhibitory protein (vFLIP) , 2004 .
[83] Mark P. Mattson,et al. NF-κB in neuronal plasticity and neurodegenerative disorders , 2001 .
[84] R. Hrdličková,et al. Mechanism of Telomerase Activation by v-Rel and Its Contribution to Transformation , 2006, Journal of Virology.
[85] Marcel Leist,et al. Four deaths and a funeral: from caspases to alternative mechanisms , 2001, Nature Reviews Molecular Cell Biology.
[86] N. Perkins,et al. p53- and Mdm2-Independent Repression of NF-κB Transactivation by the ARF Tumor Suppressor , 2003 .
[87] Yizheng Wang,et al. Low K+ Promotes NF-κB/DNA Binding in Neuronal Apoptosis Induced by K+ Loss , 2006, Molecular and Cellular Biology.
[88] J. Monroe,et al. NF-κB inducible genes BCL-X and cyclin E promote immature B-cell proliferation and survival , 2004 .
[89] Peter Schotte,et al. Caspase-11 Gene Expression in Response to Lipopolysaccharide and Interferon-γ Requires Nuclear Factor-κB and Signal Transducer and Activator of Transcription (STAT) 1* , 2002, The Journal of Biological Chemistry.
[90] J. Tschopp,et al. NF-κB Signals Induce the Expression of c-FLIP , 2001, Molecular and Cellular Biology.
[91] R. Siebert,et al. Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma. , 2003, Blood.
[92] M. Arsura,et al. X-linked Inhibitor of Apoptosis (XIAP) Inhibits c-Jun N-terminal Kinase 1 (JNK1) Activation by Transforming Growth Factor β1 (TGF-β1) through Ubiquitin-mediated Proteosomal Degradation of the TGF-β1-activated Kinase 1 (TAK1)* , 2005, Journal of Biological Chemistry.
[93] J. Tschopp,et al. Caspase-independent cell death in T lymphocytes , 2003, Nature Immunology.
[94] U. Siebenlist,et al. Control of lymphocyte development by nuclear factor-κB , 2005, Nature Reviews Immunology.
[95] A. Baldwin. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. , 2001, The Journal of clinical investigation.
[96] Steve Gerondakis,et al. The anti‐apoptotic activities of Rel and RelA required during B‐cell maturation involve the regulation of Bcl‐2 expression , 2000, The EMBO journal.
[97] Todd,et al. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning , 2002, Nature Medicine.
[98] R. Gaynor,et al. Sulindac Inhibits Activation of the NF-κB Pathway* , 1999, The Journal of Biological Chemistry.
[99] Ash A. Alizadeh,et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.
[100] Shao-Cong Sun,et al. Regulation of T cell development by the deubiquitinating enzyme CYLD , 2006, Nature Immunology.
[101] H. Pahl. Activators and target genes of Rel/NF-κB transcription factors , 1999, Oncogene.
[102] T. Gilmore,et al. Inhibitors of NF-κB signaling: 785 and counting , 2006, Oncogene.
[103] K. Tamai,et al. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes , 1996, Nature.
[104] C. Gélinas,et al. Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-κB , 2001, Nature Cell Biology.
[105] Christian Stehlik,et al. Nuclear Factor (NF)-κB–regulated X-chromosome–linked iap Gene Expression Protects Endothelial Cells from Tumor Necrosis Factor α–induced Apoptosis , 1998, The Journal of experimental medicine.
[106] Michael Karin,et al. NF-κB in cancer: a marked target , 2003 .
[107] M. You,et al. ch-IAP1, a member of the inhibitor-of-apoptosis protein family, is a mediator of the antiapoptotic activity of the v-Rel oncoprotein , 1997, Molecular and cellular biology.
[108] Haruo Okado,et al. Tumor Necrosis Factor Induces Bcl-2 and Bcl-x Expression through NFκB Activation in Primary Hippocampal Neurons* , 1999, The Journal of Biological Chemistry.
[109] Peter Scheurich,et al. NFκB activation by Fas is mediated through FADD, caspase-8, and RIP and is inhibited by FLIP , 2004, The Journal of cell biology.
[110] R. Gaynor,et al. The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β , 1998, Nature.
[111] Peter Scheurich,et al. NF-κB Inducers Upregulate cFLIP, a Cycloheximide-Sensitive Inhibitor of Death Receptor Signaling , 2001, Molecular and Cellular Biology.
[112] M. Lotze,et al. Addicted to Death: Invasive Cancer and the Immune Response to Unscheduled Cell Death , 2005, Journal of immunotherapy.
[113] M. Peter,et al. NF‐κB protects from the lysosomal pathway of cell death , 2003, The EMBO Journal.
[114] S. Ghosh,et al. 'PPAR'ting ways with inflammation , 2005, Nature Immunology.
[115] M. Naumann,et al. INK4 cell cycle inhibitors direct transcriptional inactivation of NF-κB , 1999, Oncogene.
[116] S. Thorgeirsson,et al. Regulation of α-Fetoprotein by Nuclear Factor-κB Protects Hepatocytes from Tumor Necrosis Factor-α Cytotoxicity during Fetal Liver Development and Hepatic Oncogenesis , 2004, Cancer Research.
[117] P. Khavari,et al. Alterations in NF-κB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-κB , 1998 .
[118] P. Romeo,et al. RelA repression of RelB activity induces selective gene activation downstream of TNF receptors. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[119] A. Ryo,et al. Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. , 2003, Molecular cell.
[120] Haidong Dong,et al. Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion , 2002, Nature Medicine.
[121] A. Strasser,et al. Bcl-2 transgene expression fails to prevent fatal hepatocyte apoptosis induced by endogenous TNFα in mice lacking RelA , 2006, Cell Death and Differentiation.
[122] N. Perkins,et al. Good cop, bad cop: the different faces of NF-κB , 2006, Cell Death and Differentiation.
[123] Claus Scheidereit,et al. IκB kinase complexes: gateways to NF-κB activation and transcription , 2006, Oncogene.
[124] E. Kieff,et al. NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[125] Jeung-Hoon Lee,et al. IFN-gamma regulates the expression of B7-H1 in dermal fibroblast cells. , 2005, Journal of dermatological science.
[126] B. Vandenbunder,et al. Rel/NF-κB Transcription Factors Protect against Tumor Necrosis Factor (TNF)-related Apoptosis-inducing Ligand (TRAIL)-induced Apoptosis by Up-regulating the TRAIL Decoy Receptor DcR1* , 2001, The Journal of Biological Chemistry.
[127] M. Hatano,et al. Transcriptional activation of survivin through the NF‐κB pathway by human T‐cell leukemia virus type I tax , 2005, International journal of cancer.
[128] J. Hiscott,et al. Manipulation of the nuclear factor-κB pathway and the innate immune response by viruses , 2006, Oncogene.
[129] T. Yamazaki,et al. Contribution of BCAP to maintenance of mature B cells through c-Rel , 2003, Nature Immunology.
[130] J. Králová,et al. Differential Regulation of the Inhibitor of Apoptosis ch-IAP1 by v-rel and the Proto-Oncogene c-rel , 2002, Journal of Virology.
[131] T. Wirth,et al. NF-kappaB transcription factors: critical regulators of hematopoiesis and neuronal survival. , 2000, Cytokine & growth factor reviews.
[132] J. Sedivy,et al. c-Myc Sensitizes Cells to Tumor Necrosis Factor-mediated Apoptosis by Inhibiting Nuclear Factor κB Transactivation* , 2002, The Journal of Biological Chemistry.
[133] E. Harhaj,et al. Gene expression profiles in HTLV-I-immortalized T cells: deregulated expression of genes involved in apoptosis regulation , 1999, Oncogene.
[134] G. Sonenshein,et al. Notch1 augments NF‐κB activity by facilitating its nuclear retention , 2006 .
[135] R. Jain,et al. The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis , 2004, Nature.
[136] Michael Karin,et al. NF-κB in cancer: from innocent bystander to major culprit , 2002, Nature Reviews Cancer.
[137] G. Franzoso,et al. Mutual cross-talk between reactive oxygen species and nuclear factor-kappa B: molecular basis and biological significance , 2006, Oncogene.
[138] Amer A. Beg,et al. Regulation of Developing B Cell Survival by RelA-Containing NF-κB Complexes 1 , 2003, The Journal of Immunology.
[139] P. Barker,et al. Nuclear factor-kappaB induced by doxorubicin is deficient in phosphorylation and acetylation and represses nuclear factor-kappaB-dependent transcription in cancer cells. , 2005, Cancer research.
[140] R. Paus,et al. Cylindroma as tumor of hair follicle origin. , 2006, The Journal of investigative dermatology.
[141] E. Cesarman,et al. KSHV vFLIP Is Essential for the Survival of Infected Lymphoma Cells , 2004, The Journal of experimental medicine.
[142] Masakazu Toi,et al. Nuclear factor-κB inhibitors as sensitizers to anticancer drugs , 2005, Nature Reviews Cancer.
[143] Tudor M. Baetu,et al. Disruption of NF-κB Signaling Reveals a Novel Role for NF-κB in the Regulation of TNF-Related Apoptosis-Inducing Ligand Expression1 , 2001, The Journal of Immunology.
[144] M. Kannagi,et al. Induction of Bcl-xL Expression by Human T-Cell Leukemia Virus Type 1 Tax through NF-κB in Apoptosis-Resistant T-Cell Transfectants with Tax , 1999, Journal of Virology.
[145] E. Cesarman,et al. NF-kappaB is essential for the progression of KSHV- and EBV-infected lymphomas in vivo. , 2006, Blood.
[146] Somasekar Seshagiri,et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling , 2004, Nature.
[147] Elisabeth Naschberger,et al. EBV latent membrane protein-1 protects B cells from apoptosis by inhibition of BAX. , 2005, Blood.
[148] I. Verma,et al. NF-κB regulation in the immune system , 2002, Nature Reviews Immunology.
[149] R. Sun,et al. NF-κB Inhibits Gammaherpesvirus Lytic Replication , 2003, Journal of Virology.
[150] L. Kirshenbaum,et al. Nuclear Factor- (cid:1) B–Mediated Cell Survival Involves Transcriptional Silencing of the Mitochondrial Death Gene BNIP3 in Ventricular Myocytes , 2022 .
[151] D. Baltimore,et al. Targeted Mutation of TNF Receptor I Rescues the RelA-Deficient Mouse and Reveals a Critical Role for NF-κB in Leukocyte Recruitment1 , 2001, The Journal of Immunology.
[152] D. Baltimore,et al. Physiological functions for brain NF-κB , 2005, Trends in Neurosciences.
[153] F. Weih,et al. NFκB Controls the Balance between Fas and Tumor Necrosis Factor Cell Death Pathways during T Cell Receptor-induced Apoptosis Via the Expression of Its Target Gene A20* , 2003, Journal of Biological Chemistry.
[154] G. Sledge,et al. Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth , 1997, Molecular and cellular biology.
[155] C. Y. Wang,et al. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. , 1998, Science.
[156] David F. Kashatus,et al. Expression of the Bcl-3 proto-oncogene suppresses p53 activation. , 2006, Genes & development.
[157] Sang-Gu Hwang,et al. p38 Kinase Regulates Nitric Oxide-induced Apoptosis of Articular Chondrocytes by Accumulating p53 via NFκB-dependent Transcription and Stabilization by Serine 15 Phosphorylation* , 2002, The Journal of Biological Chemistry.
[158] M. Moskowitz,et al. Dual Role of Caspase-11 in Mediating Activation of Caspase-1 and Caspase-3 under Pathological Conditions , 2000, The Journal of cell biology.
[159] J C Reed,et al. IAPs block apoptotic events induced by caspase‐8 and cytochrome c by direct inhibition of distinct caspases , 1998, The EMBO journal.
[160] Michael Karin,et al. Reactive Oxygen Species Promote TNFα-Induced Death and Sustained JNK Activation by Inhibiting MAP Kinase Phosphatases , 2005, Cell.
[161] H. Ichijo,et al. Stress-responsive protein kinases in redox-regulated apoptosis signaling. , 2005, Antioxidants & redox signaling.
[162] A. Israël,et al. NF-κB Regulates Spatial Memory Formation and Synaptic Plasticity through Protein Kinase A/CREB Signaling , 2006, Molecular and Cellular Biology.
[163] A. Baldwin,et al. Glycogen Synthase Kinase 3β Functions To Specify Gene-Specific, NF-κB-Dependent Transcription , 2005, Molecular and Cellular Biology.
[164] R. Flavell,et al. JNK potentiates TNF-stimulated necrosis by increasing the production of cytotoxic reactive oxygen species. , 2004, Genes & development.
[165] A. Strasser,et al. B Lymphocytes Differentially Use the Rel and Nuclear Factor κB1 (NF-κB1) Transcription Factors to Regulate Cell Cycle Progression and Apoptosis in Quiescent and Mitogen-activated Cells , 1998, The Journal of experimental medicine.
[166] Michael Karin,et al. IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer , 2004, Cell.
[167] R. Sen,et al. NF-κB-Dependent Regulation of the Timing of Activation-Induced Cell Death of T Lymphocytes1 , 2006, The Journal of Immunology.
[168] D. Katz,et al. Inhibition of NF‐kappaB/Rel induces apoptosis of murine B cells. , 1996, The EMBO journal.
[169] C. Pham,et al. The NF-κB-mediated control of the JNK cascade in the antagonism of programmed cell death in health and disease , 2006, Cell Death and Differentiation.
[170] Ye Zheng,et al. NF-κB RelA (p65) Is Essential for TNF-α-Induced Fas Expression but Dispensable for Both TCR-Induced Expression and Activation-Induced Cell Death1 , 2001, The Journal of Immunology.
[171] R. Brasseur,et al. Exclusive Ubiquitination and Sumoylation on Overlapping Lysine Residues Mediate NF-κB Activation by the Human T-Cell Leukemia VirusTax Oncoprotein , 2005, Molecular and Cellular Biology.
[172] Liming Yang,et al. A loss-of-function RNA interference screen for molecular targets in cancer , 2006, Nature.
[173] C. Brosnan,et al. Cytokines: Powerful Regulators of Glial Cell Activation , 2003, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[174] L. Owen-Schaub,et al. Activation-Dependent Transcriptional Regulation of the Human fas Promoter Requires NF-κB p50-p65 Recruitment , 1999, Molecular and Cellular Biology.
[175] Mei X. Wu,et al. Distinct Domains for Anti- and Pro-apoptotic Activities of IEX-1* , 2006, Journal of Biological Chemistry.
[176] Takahiro Doi,et al. NF‐κB inhibits TNF‐induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death , 2003, The EMBO journal.
[177] Francesca Zazzeroni,et al. Ferritin Heavy Chain Upregulation by NF-κB Inhibits TNFα-Induced Apoptosis by Suppressing Reactive Oxygen Species , 2004, Cell.
[178] S. Saccani,et al. Degradation of Promoter-bound p65/RelA Is Essential for the Prompt Termination of the Nuclear Factor κB Response , 2004, The Journal of experimental medicine.
[179] G. Xiao,et al. NF-κB Signaling Pathway Governs TRAIL Gene Expression and Human T-cell Leukemia Virus-I Tax-induced T-cell Death* , 2001, The Journal of Biological Chemistry.
[180] Ulrich Siebenlist,et al. Constitutive Nuclear Factor κB Activity Is Required for Survival of Activated B Cell–like Diffuse Large B Cell Lymphoma Cells , 2001, The Journal of experimental medicine.
[181] Soo Young Lee,et al. Fas-associated Factor-1 Inhibits Nuclear Factor-κB (NF-κB) Activity by Interfering with Nuclear Translocation of the RelA (p65) Subunit of NF-κB* , 2004, Journal of Biological Chemistry.
[182] N. Perkins,et al. Cisplatin mimics ARF tumor suppressor regulation of RelA (p65) nuclear factor-kappaB transactivation. , 2006, Cancer research.
[183] C V Jongeneel,et al. Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages , 1990, The Journal of experimental medicine.
[184] F. Ikeda,et al. CYLD in Ubiquitin Signaling and Tumor Pathogenesis , 2006, Cell.
[185] M. Malim,et al. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[186] J. Tschopp,et al. cFLIP regulation of lymphocyte activation and development , 2006, Nature Reviews Immunology.
[187] Stephanie Birkey Reffey,et al. Characterization of XIAP-Deficient Mice , 2001, Molecular and Cellular Biology.
[188] J. Tschopp,et al. PIDD Mediates NF-κB Activation in Response to DNA Damage , 2005, Cell.
[189] G. Courtois,et al. The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination , 2003, Nature.
[190] N. Perkins,et al. p53 Represses Cyclin D1 Transcription through Down Regulation of Bcl-3 and Inducing Increased Association of the p52 NF-κB Subunit with Histone Deacetylase 1 , 2003, Molecular and Cellular Biology.
[191] C. Gélinas,et al. The Rel/NF-κB Family Directly Activates Expression of the Apoptosis Inhibitor Bcl-xL , 2000, Molecular and Cellular Biology.
[192] H. Liou. NF-κB/Rel Transcription Factor Family , 2006 .
[193] S. Shumway,et al. NF-kappaB activation by camptothecin. A linkage between nuclear DNA damage and cytoplasmic signaling events. , 2000, The Journal of biological chemistry.
[194] B. Aggarwal,et al. Evidence that activation of nuclear factor-kappaB is essential for the cytotoxic effects of doxorubicin and its analogues. , 2004, Biochemical pharmacology.
[195] Jian J Lu,et al. Tumor necrosis factor-α induces the expression of DR6, a member of the TNF receptor family, through activation of NF-κB , 2001, Oncogene.
[196] F. Zazzeroni,et al. Cell signalling (communication arising): Cell survival and a Gadd45-factor deficiency , 2003, Nature.
[197] E. J. Green,et al. Inhibition of astroglial nuclear factor κB reduces inflammation and improves functional recovery after spinal cord injury , 2005, The Journal of experimental medicine.
[198] M. Karin,et al. Inhibition of JNK activation through NF-κB target genes , 2001, Nature.
[199] B. Dörken,et al. Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. , 1997, The Journal of clinical investigation.
[200] A. Israël,et al. IκBα/IκBε deficiency reveals that a critical NF-κB dosage is required for lymphocyte survival , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[201] W. Zong,et al. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-κB that blocks TNFα-induced apoptosis , 1999 .
[202] Olivier Hermine,et al. Vital functions for lethal caspases , 2005, Oncogene.
[203] C. Thompson,et al. Death by design: apoptosis, necrosis and autophagy. , 2004, Current opinion in cell biology.
[204] G. Wahl,et al. p53 stabilization is decreased upon NFκB activation , 2002 .
[205] S. Korsmeyer,et al. Review Cell Death: Critical Control Points Another Line of Evidence for the Importance of Caspases in Cell Death Came From , 2022 .
[206] J. Borowitz,et al. NF‐κB‐mediated up‐regulation of Bcl‐XS and Bax contributes to cytochrome c release in cyanide‐induced apoptosis , 2002, Journal of neurochemistry.
[207] U. Siebenlist,et al. NF-κB guides the survival and differentiation of developing lymphocytes , 2006, Cell Death and Differentiation.
[208] Amir Gamliel,et al. A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ , 2005, Nature.
[209] G. Fuller,et al. Analysis of the activation status of Akt, NFκB, and Stat3 in human diffuse gliomas , 2004, Laboratory Investigation.
[210] Seamus J. Martin,et al. Inhibition of TNF-induced apoptosis by NF-κB , 1998 .
[211] R. Kaufman,et al. Autocrine Tumor Necrosis Factor Alpha Links Endoplasmic Reticulum Stress to the Membrane Death Receptor Pathway through IRE1α-Mediated NF-κB Activation and Down-Regulation of TRAF2 Expression , 2006, Molecular and Cellular Biology.
[212] I. Screpanti,et al. TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma. , 2004, Cancer cell.
[213] G. Salvesen,et al. The Human Anti-apoptotic Proteins cIAP1 and cIAP2 Bind but Do Not Inhibit Caspases* , 2006, Journal of Biological Chemistry.
[214] Y. Ben-Neriah,et al. NF-κB functions as a tumour promoter in inflammation-associated cancer , 2004, Nature.
[215] Honglin Zhou,et al. Bcl10 activates the NF-κB pathway through ubiquitination of NEMO , 2004, Nature.
[216] A. Baldwin,et al. Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression , 2006, Oncogene.
[217] M. Mattson,et al. Roles for NF-κB in nerve cell survival, plasticity, and disease , 2006, Cell Death and Differentiation.
[218] Jennifer Y. Zhang,et al. NF-kappaB RelA opposes epidermal proliferation driven by TNFR1 and JNK. , 2004, Genes & development.
[219] Francesca Zazzeroni,et al. Induction of gadd45β by NF-κB downregulates pro-apoptotic JNK signalling , 2001, Nature.
[220] L. Coussens,et al. The interplay between innate and adaptive immunity regulates cancer development , 2005, Cancer Immunology, Immunotherapy.
[221] R. Davis,et al. Signal Transduction by the JNK Group of MAP Kinases , 2000, Cell.
[222] Marty W. Mayo,et al. NF-κB Induces Expression of the Bcl-2 Homologue A1/Bfl-1 To Preferentially Suppress Chemotherapy-Induced Apoptosis , 1999, Molecular and Cellular Biology.
[223] S. Gerondakis,et al. Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis. , 1999, Genes & development.
[224] A. Polack,et al. Inducible loss of NF-kappaB activity is associated with apoptosis and Bcl-2 down-regulation in Epstein-Barr virus-transformed B lymphocytes. , 2000, Blood.